cat |
LDLo |
intravenous |
150mg/kg (150mg/kg) |
|
"Antibiotics: Origin, Nature, and Properties," Korzyoski, T., et al., eds., Washington, DC, American Soc. for Microbiology, 1978Vol. 1, Pg. 570, 1978. |
cat |
LDLo |
oral |
2gm/kg (2000mg/kg) |
|
"Antibiotics: Origin, Nature, and Properties," Korzyoski, T., et al., eds., Washington, DC, American Soc. for Microbiology, 1978Vol. 1, Pg. 570, 1978. |
cat |
LDLo |
subcutaneous |
600mg/kg (600mg/kg) |
|
"Antibiotics: Origin, Nature, and Properties," Korzyoski, T., et al., eds., Washington, DC, American Soc. for Microbiology, 1978Vol. 1, Pg. 570, 1978. |
dog |
LDLo |
subcutaneous |
300mg/kg (300mg/kg) |
|
"Antibiotics: Origin, Nature, and Properties," Korzyoski, T., et al., eds., Washington, DC, American Soc. for Microbiology, 1978Vol. 1, Pg. 570, 1978. |
guinea pig |
LDLo |
subcutaneous |
600mg/kg (600mg/kg) |
|
"Antibiotics: Origin, Nature, and Properties," Korzyoski, T., et al., eds., Washington, DC, American Soc. for Microbiology, 1978Vol. 1, Pg. 570, 1978. |
human |
TDLo |
intraperitoneal |
143mg/kg (143mg/kg) |
VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION
LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION
LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES |
British Medical Journal. Vol. 1, Pg. 556, 1961. |
human |
TDLo |
oral |
400mg/kg/28D- (400mg/kg) |
SENSE ORGANS AND SPECIAL SENSES: CHANGES IN VESTIBULAR FUNCTIONS: EAR |
Revue Medicale de la Suisse Romande. Vol. 73, Pg. 854, 1953. |
human |
TDLo |
parenteral |
28mg/kg/D (28mg/kg) |
BLOOD: EOSINOPHILIA |
Revue Medicale de la Suisse Romande. Vol. 73, Pg. 820, 1953. |
monkey |
LDLo |
subcutaneous |
400mg/kg (400mg/kg) |
|
"Antibiotics: Origin, Nature, and Properties," Korzyoski, T., et al., eds., Washington, DC, American Soc. for Microbiology, 1978Vol. 1, Pg. 570, 1978. |
mouse |
LD50 |
intraperitoneal |
525mg/kg (525mg/kg) |
|
Strahlentherapie. Vol. 127, Pg. 245, 1965. |
mouse |
LD50 |
intravenous |
90200ug/kg (90.2mg/kg) |
|
Antibiotiki. Vol. 18, Pg. 249, 1973. |
mouse |
LD50 |
oral |
500mg/kg (500mg/kg) |
|
Yakkyoku. Pharmacy. Vol. 38, Pg. 1493, 1987. |
mouse |
LD50 |
subcutaneous |
520mg/kg (520mg/kg) |
|
British Journal of Pharmacology and Chemotherapy. Vol. 15, Pg. 496, 1960. |
mouse |
LD50 |
unreported |
90mg/kg (90mg/kg) |
|
Arzneimittel-Forschung. Drug Research. Vol. 5, Pg. 213, 1955. |
rabbit |
LDLo |
intravenous |
175mg/kg (175mg/kg) |
|
Naturwissenschaften. Vol. 43, Pg. 183, 1956. |
rabbit |
LDLo |
subcutaneous |
600mg/kg (600mg/kg) |
|
"Antibiotics: Origin, Nature, and Properties," Korzyoski, T., et al., eds., Washington, DC, American Soc. for Microbiology, 1978Vol. 1, Pg. 570, 1978. |
rat |
LD50 |
oral |
9gm/kg (9000mg/kg) |
|
"Agricultural Chemicals," Thomson, W.T., 4 vols., Fresno, CA, Thomson Publications, 1976/77 revisionVol. 4, Pg. 35, 1976/1977. |
rat |
LDLo |
intravenous |
175mg/kg (175mg/kg) |
|
"Antibiotics: Origin, Nature, and Properties," Korzyoski, T., et al., eds., Washington, DC, American Soc. for Microbiology, 1978Vol. 1, Pg. 570, 1978. |
rat |
LDLo |
subcutaneous |
600mg/kg (600mg/kg) |
|
"Antibiotics: Origin, Nature, and Properties," Korzyoski, T., et al., eds., Washington, DC, American Soc. for Microbiology, 1978Vol. 1, Pg. 570, 1978. |